FDA label
What is Kerendia used for?
Kerendia contains finerenone. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Kerendia is indicated to: reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with Type 2 diabetes mellitus (T2DM); reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduc...”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Kerendia?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Kerendia, tablet, film coated
Indications and Usage, quoted from the label by Bayer HealthCare Pharmaceuticals Inc. (NDA215341). Cross-references to other label sections are left out.
Kerendia is indicated to:
- reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with Type 2 diabetes mellitus (T2DM).
- reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained eGFR decline and end-stage kidney disease in adults with CKD associated with Type 1 diabetes mellitus (T1DM).
- reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure with left ventricular ejection fraction (LVEF) ≥ 40%.
Source: DailyMed label, set id fc726765-5d5a-4d6e-b037-b847bda9fb7c, version 15, effective September 21, 2026. NDC 50419-540, one of 2 listings for this product.
Questions
What is Kerendia used for?
The FDA label says: “Kerendia is indicated to: reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with Type 2 diabetes mellitus (T2DM); reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduc...”
What drug class is Kerendia?
FDA lists finerenone in the Nonsteroidal Mineralocorticoid-Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Kerendia
- Is Kerendia a controlled substance?Federal schedule
- Generic for KerendiaFDA Orange Book
- Nonsteroidal Mineralocorticoid-Receptor Antagonists listFDA drug class
- Kerendia Medicare Part D coverageBy plan and state
- NDC 50419-540Kerendia NDC record
- NDC 50419-541Kerendia NDC record
- NDC 50419-542Kerendia NDC record